As of 30 Sep 2025, 42 institutional investors reported holding $299,324,000 in principal (par value) of HAEMONETICS CORP MASS - NOTE 3/0.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $860,000 | $849,129 | +$15,783 | 98.4% | 3 |
| 2025 Q3 | $299,324,000 | $293,438,296 | +$2,098,325 | 97.76% | 42 |
| 2025 Q2 | $297,562,000 | $287,850,876 | +$2,025,392 | 96.5% | 43 |
| 2025 Q1 | $295,109,639 | $282,286,333 | +$2,783,545 | 95.44% | 44 |
| 2024 Q4 | $292,307,277 | $275,910,787 | -$9,147,417 | 94.13% | 45 |
| 2024 Q3 | $303,732,277 | $281,293,777 | -$18,502,186 | 92.5% | 51 |
| 2024 Q2 | $324,676,273 | $293,289,879 | -$199,609,301 | 90.15% | 47 |
| 2024 Q1 | $538,925,331 | $502,061,838 | -$13,353,742,550 | 91.96% | 49 |
| 2023 Q4 | $495,645,344 | $442,147,642 | +$20,282,323 | 89.05% | 47 |
| 2023 Q3 | $471,885,170 | $412,030,565 | +$3,879,149 | 86.83% | 51 |
| 2023 Q2 | $467,571,318 | $401,252,073 | -$2,136,061 | 85.44% | 51 |
| 2023 Q1 | $468,923,009 | $399,453,244 | +$26,559,166 | 85.05% | 46 |
| 2022 Q4 | $438,307,098 | $364,276,052 | -$4,237,742 | 83.13% | 48 |
| 2022 Q3 | $442,309,775 | $354,988,164 | -$3,162,666 | 80.0% | 51 |
| 2022 Q2 | $446,562,359 | $352,231,878 | +$21,406,997 | 78.76% | 43 |
| 2022 Q1 | $438,877,655 | $370,775,206 | +$370,775,196 | 84.21% | 35 |